|

Abexinostat Clinical Trials

2 actively recruiting trials across 1 location

Also known as: PCI-24781

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Xynomic Pharmaceuticals, Inc.2

Indications

  • Cancer2
  • Renal Cell Carcinoma1
  • Diffuse Large B-cell Lymphoma(DLBCL)1

Other1 trial

Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Phase 2

Phoenix, Arizona1 trial

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

University Of UA Cancer Center(UACC)/DH-SJHMC

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.